J Lange

1.2k total citations
23 papers, 910 citations indexed

About

J Lange is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, J Lange has authored 23 papers receiving a total of 910 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 15 papers in Virology and 5 papers in Emergency Medicine. Recurrent topics in J Lange's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (10 papers). J Lange is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (10 papers). J Lange collaborates with scholars based in Netherlands, Germany and Thailand. J Lange's co-authors include Jaap Goudsmit, Jaap Goudsmit, Maarten Koot, J. van der Noordaa, Frank Miedema, Jan W. Mulder, Paul Kellam, Brendan Larder, F de Wolf and Ireneus P.M. Keet and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Clinical Infectious Diseases.

In The Last Decade

J Lange

22 papers receiving 883 citations

Peers

Countries citing papers authored by J Lange

Since Specialization

Citations

This map shows the geographic impact of J Lange's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Lange with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Lange more than expected).

Fields of papers citing papers by J Lange

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Lange. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Lange. The network helps show where J Lange may publish in the future.

Co-authorship network of co-authors of J Lange

This figure shows the co-authorship network connecting the top 25 collaborators of J Lange. A scholar is included among the top collaborators of J Lange based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Lange. J Lange is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Age-dependent oral drug absorption in children: Assessment of a bottom-up modelling approach 2025 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), J Lange, Sandra Klein	0
2	Implementation of TasP: challenges and opportunities 2014 ·BMC Infectious Diseases ·J Lange	1
3	Pharmacokinetics and short-term efficacy of a double-boosted protease inhibitor regimen in treatment-naive HIV-1-infected adults 2008 ·Journal of Antimicrobial Chemotherapy ·Jasper van der Lugt, (unknown), Sasiwimol Ubolyam, (unknown), (unknown), (unknown), (unknown), David A. Cooper, J Lange, Praphan Phanuphak, Ferdinand W.N.M. Wit, Kiat Ruxrungtham, Dylan Burger, (unknown)	24
4	No Virological Failure in Semen During Properly Suppressive Antiretroviral Therapy Despite Subtherapeutic Local Drug Concentrations 2006 ·HIV Clinical Trials ·(unknown), Annemarie M. J. Wensing, J. A. H. Droste, (unknown), Suzanne Jurriaans, David M. Burger, Jan C.C. Borleffs, J Lange, (unknown)	2
5	Creation of a drug fund for post-clinical trial access to antiretrovirals 2004 ·The Lancet ·Jintanat Ananworanich, (unknown), (unknown), Mark Boyd, Kiat Ruxrungtham, J Lange, David A. Cooper, Praphan Phanuphak	21
6	Nelfinavir Plasma Concentrations Are Low during Pregnancy 2004 ·Clinical Infectious Diseases ·(unknown), (unknown), (unknown), Alina S Bergshoeff, (unknown), Kees Boer, J Lange, D.M. Burger, Jan M. Prins	31
7	Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily 2004 ·Journal of Antimicrobial Chemotherapy ·Reshma Autar, Jintanat Ananworanich, (unknown), (unknown), Andrew Hill, Bernard Hirschel, David A. Cooper, J Lange, Praphan Phanuphak, Kiat Ruxrungtham, Danielle Burger	35
8	Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA 2000 ·Journal of Clinical Investigation ·Gian Paolo Rizzardi, Rob J. de Boer, Shelley Hoover, Giuseppe Tambussi, Aude G. Chapuis, Nermin Halkic, Pierre‐Alexandre Bart, Veronica Miller, Schlomo Staszewski, Daan W. Notermans, Luc Perrin, Cecil H. Fox, J Lange, Adriano Lazzarin, (unknown)	39
9	Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detection 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·Agnes I. Veldkamp, Rolf P. G. van Heeswijk, Richard M. W. Hoetelmans, Pieter L. Meenhorst, Jan W. Mulder, J Lange, J. H. Beijnen	7
10	New antiretrovirals and new combinations. 1998 ·PubMed ·Diane V. Havlir, J Lange	23
11	[The history of laparoscopy]. 1997 ·PubMed ·(unknown), J Lange	1
12	Distinct Changes in HIV Type 1 RNA versus p24 Antigen Levels in Serum during Short-Term Zidovudine Therapy in Asymptomatic Individuals with and without Progression to AIDS 1995 ·AIDS Research and Human Retroviruses ·Suzanne Jurriaans, Gerrit‐Jan Weverling, Jaap Goudsmit, Jossy van den Boogaard, Melina G.H.E. den Brok, Dianne van Strijp, J Lange, M. Koot, Bob van Gemen	20
13	Herpes zoster, immunological deterioration and disease progression in HIV-1 infection 1995 ·AIDS ·Jan A. Veenstra, Anneke Krol, Rieneke M. E. van Praag, (unknown), Peter Th.A. Schellekens, J Lange, Roel A. Coutinho, Jan T. M. van der Meer	89
14	The feasibility, reliability and validity of the EORTC QLQ-C30 in assessing the quality of life of patients with a symptomatic HIV infection or AIDS (CDC IV) 1994 ·Psychology and Health ·Josien B. de Boer, Mirjam A. G. Sprangers, Neil K. Aaronson, J Lange, Frits S.A.M. van Dam	24
15	Predictors of rapid progression to AIDS in HIV-1 seroconverters 1993 ·AIDS ·Ireneus P.M. Keet, Pieta Krijnen, Maarten Koot, J Lange, Frank Miedema, Jaap Goudsmit, R A Coutinho	121
16	Experts call for urgent development of microbicides. 1993 ·PubMed ·J Lange	1
17	HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment 1992 ·AIDS ·(unknown), J Lange, Frank Miedema, Gerrit Jan Weverling, Maarten Koot, Jan W. Mulder, Jaap Goudsmit, Paul Kellam, Brendan Larder, (unknown)	79
18	Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy 1990 ·The Lancet ·Charles A. Boucher, J Lange, Jaap Goudsmit, Jan W. Mulder, M Tersmette, R. E. Y. de Goede, Paul Kellam, G. Darby, Brendan Larder	148
19	Antibody response to the viral negative factor (nef) in HIV-1 infection 1989 ·AIDS ·Peter Reiss, Anthony de Ronde, J Lange, Frank de Wolf, John T. Dekker, Christine Debouck, Jaap Goudsmit	45
20	Pathogenesis of HIV and its implications for serodiagnosis and monitoring of antiviral therapy 1987 ·Journal of Virological Methods ·Jaap Goudsmit, J Lange, W Krone, Marcel B. M. Teunissen, Leon G. Epstein, Sven A. Danner, Henk van den Berg, C. Breederveld, (unknown), Margreet Bakker, Frank de Wolf, Roel A. Coutinho, J. van der Noordaa	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact